FIELD: chemistry.
SUBSTANCE: invention relates to a compound of general formula (I)
in which R is a branched butyl. The invention also relates to a pharmaceutical composition having a phosphodiesterase inhibitory activity, to the use of a compound for the preparation of a pharmaceutical composition, and to a method of treating or reducing the intensity of a disease, disorder or condition susceptible to a PDE4 inhibitory activity.
EFFECT: new compound of general formula I, having a phosphodiesterase inhibitory activity, was obtained.
10 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATING SKIN DISEASES | 2009 |
|
RU2544011C2 |
SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS | 2014 |
|
RU2802185C2 |
DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE | 2009 |
|
RU2514937C2 |
USE OF 1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS | 2017 |
|
RU2759380C2 |
SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS | 2014 |
|
RU2668073C2 |
INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
BICYCLIC KETONES AND METHODS OF THEIR USE | 2018 |
|
RU2797922C2 |
KINASE INHIBITORS | 2013 |
|
RU2637944C2 |
TETRAHYDROTRIAZOLOPYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN NEUTROPHIL ELASTASE | 2012 |
|
RU2622643C2 |
COMPOUNDS WITH SPIRO AND AROMATIC RINGS AND APPLICATION THEREOF | 2019 |
|
RU2781100C1 |
Authors
Dates
2017-09-12—Published
2012-12-19—Filed